Clinical Trials Browser

Down Syndrome × Daunorubicin × 90 days × Clear all

NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma